Biopejs-shop.dk ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.5% 1.4% 1.0% 1.2% 0.5%  
Credit score (0-100)  79 79 86 80 99  
Credit rating  BBB BBB A BBB AA  
Credit limit (kDKK)  10.8 21.9 273.3 302.6 1,992.6  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Net sales  0 0 0 0 0  
Gross profit  3,510 4,148 5,984 10,446 12,073  
EBITDA  372 436 1,596 5,952 6,790  
EBIT  291 360 1,506 5,800 6,515  
Pre-tax profit (PTP)  278.7 347.0 1,510.7 5,776.2 6,479.5  
Net earnings  211.3 262.9 1,176.9 4,499.5 5,049.3  
Pre-tax profit without non-rec. items  279 347 1,511 5,776 6,480  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Tangible assets total  659 700 733 1,450 1,175  
Shareholders equity total  1,461 1,618 2,687 6,966 11,788  
Interest-bearing liabilities  667 236 229 90.5 54.3  
Balance sheet total (assets)  3,464 3,172 4,839 10,797 18,007  

Net Debt  640 207 -723 -2,745 -6,344  
 
See the entire balance sheet

Volume 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,510 4,148 5,984 10,446 12,073  
Gross profit growth  35.2% 18.2% 44.3% 74.6% 15.6%  
Employees  11 12 12 11 12  
Employee growth %  37.5% 9.1% 0.0% -8.3% 9.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,464 3,172 4,839 10,797 18,007  
Balance sheet change%  27.5% -8.4% 52.6% 123.1% 66.8%  
Added value  290.6 360.0 1,506.4 5,799.9 6,515.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -164 -35 -57 564 -550  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  8.3% 8.7% 25.2% 55.5% 54.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.7% 11.2% 37.9% 74.2% 45.3%  
ROI %  15.7% 18.4% 59.9% 112.9% 68.6%  
ROE %  14.7% 17.1% 54.7% 93.2% 53.8%  

Solidity 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Equity ratio %  42.2% 51.0% 55.5% 66.4% 67.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  171.8% 47.5% -45.3% -46.1% -93.4%  
Gearing %  45.7% 14.6% 8.5% 1.3% 0.5%  
Net interest  0 0 0 0 0  
Financing costs %  4.9% 5.6% 2.6% 14.9% 53.4%  

Liquidity 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Quick Ratio  0.3 0.3 1.1 1.5 1.9  
Current Ratio  1.4 1.6 2.2 2.5 2.7  
Cash and cash equivalent  27.3 29.3 951.7 2,835.1 6,398.5  

Capital use efficiency 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  817.4 958.3 2,204.7 5,571.6 10,657.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Net sales / employee  0 0 0 0 0  
Added value / employee  26 30 126 527 543  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  34 36 133 541 566  
EBIT / employee  26 30 126 527 543  
Net earnings / employee  19 22 98 409 421